Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pharmaniaga BhdXKLS:7081 66 OCF Margin % is 0.84% as of Jun. 2026, which is 147% above its 10-year median of 0.34. GuruFocus rates XKLS:7081 with a GF Score™ of 66/100 and a GF Value™ of RM1.11 (Fairly Valued). The stock has 6 warning signs investors should review. Among 118 Medical Distribution companies, Pharmaniaga Bhd ranks worse than 75.42% on this metric.
The historical data trend for Pharmaniaga Bhd's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:7081 vs MCK, COR, CAH: OCF Margin % Comparison
For the Medical Distribution subindustry, Pharmaniaga Bhd's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharmaniaga Bhd OCF Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Pharmaniaga Bhd's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Pharmaniaga Bhd's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmaniaga Bhd (XKLS:7081) has a OCF Margin % of 0.84% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Pharmaniaga Bhd and its competitors. This is 147% above median its historical median of 0.34. According to the industry distribution chart, Pharmaniaga Bhd ranks #89 out of 118 companies in the Medical Distribution industry, placing it in the top 75.4%.
Is Pharmaniaga Bhd's OCF Margin % too high?
Pharmaniaga Bhd's current OCF Margin % of 0.84% is 147% above median its 10-year median of 0.34. The Medical Distribution industry median OCF Margin % is 1.85. Pharmaniaga Bhd's value of 0.84% is 54.5% below this industry median. Based on the distribution chart, Pharmaniaga Bhd ranks #89 out of 118 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Pharmaniaga Bhd has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pharmaniaga Bhd's OCF Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Pharmaniaga Bhd ranks #89 out of 118 companies for OCF Margin %. This places Pharmaniaga Bhd in the lower half of its industry. The industry median OCF Margin % is 1.85. Pharmaniaga Bhd's value of 0.84% is 54.5% below this benchmark. While the company's 10-year median is 0.34 vs. the industry median of 1.85, Pharmaniaga Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Distribution company?
The median OCF Margin % among Medical Distribution companies is 1.85, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharmaniaga Bhd's current OCF Margin % of 0.84% is 54.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Pharmaniaga Bhd and its competitors. For the Medical Distribution industry, the median OCF Margin % is 1.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharmaniaga Bhd's current OCF Margin % is 0.84%, which is 147% above median its own 10-year median of 0.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmaniaga Bhd stock overvalued right now?
Based on GuruFocus' analysis, Pharmaniaga Bhd (XKLS:7081) is currently considered Fairly Valued. The stock's GF Value™ is RM1.11, compared to a current price of RM1.19 — trading 7.2% above its estimated fair value. The current OCF Margin % is 0.84%, which is 147% above median its 10-year median of 0.34 and 54.5% below the Medical Distribution industry median of 1.85. Pharmaniaga Bhd's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Pharmaniaga Bhd (XKLS:7081), the current OCF Margin % is 0.84% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharmaniaga Bhd (XKLS:7081) Overvalued in 2026?
Based on GuruFocus' analysis, Pharmaniaga Bhd stock appears to be overvalued.
The current stock price of RM1.19 is trading 7.2% above its estimated GF Value™ of RM1.11.
GuruFocus considers Pharmaniaga Bhd to be Fairly Valued.
Key valuation signals for XKLS:7081:
OCF Margin %: 0.84% (147% above median its 10-year median of 0.34)
GF Value™: RM1.11 vs. price of RM1.19 (7.2% above fair value)
Industry Position: 54.5% below the Medical Distribution median (#89 of 118)
No single metric tells the full story. See the XKLS:7081 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharmaniaga Bhd is engaged in the manufacture of pharmaceuticals and medical devices. The company is also involved in logistics and distribution. The group operates in three segments - Logistics and distribution, Manufacturing in Malaysia, and Manufacturing and distribution in Indonesia. Maximum revenue is generated by the logistics and distribution segment in Malaysia. The Logistics and distribution segment is engaged in distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia.
66GF Score
Get the complete analysis for XKLS:7081
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7081 has been successfully added to your 
